Trovagene declares activation of 2 supplementary Clinical Trial sites to conduct Phase 1b/2 Study Read more
Phase II CONDOR Trial suggests tolerance of inhibitor durvalumab in patients with metastatic head cancer Read more
SpinalCyte’s CybroCell Dermal Fibroblasts signals positive Phase 1/2 Clinical Trial Results Read more
Bavarian Nordic announces positive results of Pivotal Phase 3 Study of IMVAMUNE smallpox vaccine Read more